C284H283ClN40O31S5 — CID 159231039
4-(5-chloro-3-cyano-1-ethylindol-2-yl)benzenesulfonamide;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-ethylurea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-phenoxyphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-phenylethyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-propan-2-ylphenyl)urea;N-[4-[3-cyano-6-methoxy-1-(2-methylpropyl)indol-2-yl]phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]ethanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-propylindol-2-yl)phenyl]methanesulfonamide;ethyl 4-[[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]carbamoylamino]benzoate (PubChem CID 159231039) has the molecular formula C284H283ClN40O31S5 and a molecular weight of 4948.43 g/mol. Its IUPAC name is 4-(5-chloro-3-cyano-1-ethylindol-2-yl)benzenesulfonamide;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-ethylurea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-phenoxyphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-phenylethyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-propan-2-ylphenyl)urea;N-[4-[3-cyano-6-methoxy-1-(2-methylpropyl)indol-2-yl]phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]ethanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-propylindol-2-yl)phenyl]methanesulfonamide;ethyl 4-[[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]carbamoylamino]benzoate.
| Compound Name | 4-(5-chloro-3-cyano-1-ethylindol-2-yl)benzenesulfonamide;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-ethylurea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-phenoxyphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-phenylethyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-propan-2-ylphenyl)urea;N-[4-[3-cyano-6-methoxy-1-(2-methylpropyl)indol-2-yl]phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]ethanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-propylindol-2-yl)phenyl]methanesulfonamide;ethyl 4-[[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]carbamoylamino]benzoate |
|---|---|
| PubChem CID | 159231039 |
| Molecular Formula | C284H283ClN40O31S5 |
| Molecular Weight | 4948.43 g/mol |
| Exact Mass | 4944.01 |
| IUPAC Name | 4-(5-chloro-3-cyano-1-ethylindol-2-yl)benzenesulfonamide;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-ethylurea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-methylphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-phenoxyphenyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(2-phenylethyl)urea;1-[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]-3-(4-propan-2-ylphenyl)urea;N-[4-[3-cyano-6-methoxy-1-(2-methylpropyl)indol-2-yl]phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]ethanesulfonamide;N-[4-(6-ethoxy-1-ethylindol-2-yl)phenyl]methanesulfonamide;N-[4-(6-ethoxy-1-propylindol-2-yl)phenyl]methanesulfonamide;ethyl 4-[[3-(3-cyano-1-ethyl-6-methoxyindol-2-yl)phenyl]carbamoylamino]benzoate |
| SMILES | CCCn1c(-c2ccc(NS(C)(=O)=O)cc2)cc2ccc(OCC)cc21.CCNC(=O)Nc1cccc(-c2c(C#N)c3ccc(OC)cc3n2CC)c1.CCOC(=O)c1ccc(NC(=O)Nc2cccc(-c3c(C#N)c4ccc(OC)cc4n3CC)c2)cc1.CCOc1ccc2cc(-c3ccc(NS(=O)(=O)CC)cc3)n(CC)c2c1.CCOc1ccc2cc(-c3ccc(NS(C)(=O)=O)cc3)n(CC)c2c1.CCn1c(-c2ccc(S(N)(=O)=O)cc2)c(C#N)c2cc(Cl)ccc21.CCn1c(-c2cccc(NC(=O)NCCc3ccccc3)c2)c(C#N)c2ccc(OC)cc21.CCn1c(-c2cccc(NC(=O)Nc3ccc(C(C)C)cc3)c2)c(C#N)c2ccc(OC)cc21.CCn1c(-c2cccc(NC(=O)Nc3ccc(C)cc3)c2)c(C#N)c2ccc(OC)cc21.CCn1c(-c2cccc(NC(=O)Nc3ccc(Oc4ccccc4)cc3)c2)c(C#N)c2ccc(OC)cc21.CCn1c(-c2cccc(NC(=O)Nc3ccccc3C)c2)c(C#N)c2ccc(OC)cc21.COc1ccc2c(C#N)c(-c3ccc(NS(C)(=O)=O)cc3)n(CC(C)C)c2c1 |
| InChI | InChI=1S/C31H26N4O3.C28H26N4O4.C28H28N4O2.C27H26N4O2.2C26H24N4O2.C21H22N4O2.C21H23N3O3S.2C20H24N2O3S.C19H22N2O3S.C17H14ClN3O2S/c1-3-35-29-19-26(37-2)16-17-27(29)28(20-32)30(35)21-8-7-9-23(18-21)34-31(36)33-22-12-14-25(15-13-22)38-24-10-5-4-6-11-24;1-4-32-25-16-22(35-3)13-14-23(25)24(17-29)26(32)19-7-6-8-21(15-19)31-28(34)30-20-11-9-18(10-12-20)27(33)36-5-2;1-5-32-26-16-23(34-4)13-14-24(26)25(17-29)27(32)20-7-6-8-22(15-20)31-28(33)30-21-11-9-19(10-12-21)18(2)3;1-3-31-25-17-22(33-2)12-13-23(25)24(18-28)26(31)20-10-7-11-21(16-20)30-27(32)29-15-14-19-8-5-4-6-9-19;1-4-30-24-15-20(32-3)12-13-21(24)22(16-27)25(30)18-9-7-10-19(14-18)28-26(31)29-23-11-6-5-8-17(23)2;1-4-30-24-15-21(32-3)12-13-22(24)23(16-27)25(30)18-6-5-7-20(14-18)29-26(31)28-19-10-8-17(2)9-11-19;1-4-23-21(26)24-15-8-6-7-14(11-15)20-18(13-22)17-10-9-16(27-3)12-19(17)25(20)5-2;1-14(2)13-24-20-11-17(27-3)9-10-18(20)19(12-22)21(24)15-5-7-16(8-6-15)23-28(4,25)26;1-4-12-22-19(13-16-8-11-18(25-5-2)14-20(16)22)15-6-9-17(10-7-15)21-26(3,23)24;1-4-22-19(13-16-9-12-18(25-5-2)14-20(16)22)15-7-10-17(11-8-15)21-26(23,24)6-3;1-4-21-18(12-15-8-11-17(24-5-2)13-19(15)21)14-6-9-16(10-7-14)20-25(3,22)23;1-2-21-16-8-5-12(18)9-14(16)15(10-19)17(21)11-3-6-13(7-4-11)24(20,22)23/h4-19H,3H2,1-2H3,(H2,33,34,36);6-16H,4-5H2,1-3H3,(H2,30,31,34);6-16,18H,5H2,1-4H3,(H2,30,31,33);4-13,16-17H,3,14-15H2,1-2H3,(H2,29,30,32);2*5-15H,4H2,1-3H3,(H2,28,29,31);6-12H,4-5H2,1-3H3,(H2,23,24,26);5-11,14,23H,13H2,1-4H3;6-11,13-14,21H,4-5,12H2,1-3H3;7-14,21H,4-6H2,1-3H3;6-13,20H,4-5H2,1-3H3;3-9H,2H2,1H3,(H2,20,22,23) |
| InChIKey | KSWZCGSHOGVIRR-UHFFFAOYSA-N |
| XLogP | 63.69 |
| TPSA | 943.08 Ų |
| H-Bond Donors | 19 |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 71 |
| Heavy Atoms | 361 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4948.43 |
| LogP ≤ 5 | 63.69 |
| H-Bond Donors ≤ 5 | 19 |
| H-Bond Acceptors ≤ 10 | 52 |